SCIENTURE Adds 12.5 Million Covered Lives to Arbli™ Payor Network Expansion
SCNX•SCIENTURE expanded payor coverage for Arbli™ to include approximately 12.5 million covered lives across Medicare Part D supplement plans and other commercial and government-sponsored healthcare channels. The company is also broadening pharmacy networks, specialty technology partnerships and Medicaid channels to drive prescription volume within the $219 million U.S. losartan market.
1. Payor Coverage Expansion
SCIENTURE secured additional payor coverage representing approximately 12.5 million covered lives, extending Arbli™ access through Medicare Part D supplement plans and various commercial and government-sponsored healthcare channels nationwide.
2. Commercial Infrastructure Initiatives
The company is strengthening Arbli™ distribution by expanding pharmacy networks, partnering with pharmacy buying groups and integrating specialty technology platforms to enhance prescription fulfillment.
3. Market Opportunity and Growth Outlook
With the U.S. losartan market valued at $219 million and 72 million annual prescriptions, even modest liquid formulation penetration could yield meaningful revenue growth and support long-term prescription volume gains.
